CONTACT US

Application Note: Carcino3D™ Lung Model as a Relevant Tool for Drug Testing

August 29, 2024

3D-printed tumors represent a significant advancement in cancer research, offering a more relevant model compared to traditional 2D cell cultures and animal models. By mimicking the complex architecture and microenvironment of human tumors, these models enable researchers to study cancer biology in a context that closely resembles human disease. This can lead to a better understanding of tumor heterogeneity, and treatment resistance, ultimately informing the development of more effective therapies.
In this application note, we present data demonstrating the similarities between a donor lung tumor tissue and Carcinotech’s 3D-bioprinted lung tumor in terms of both cellular composition and response to drug treatment. These findings highlight the potential of 3D-bioprinted models as translational tools for pre-clinical research and drug development.

Download our Application Note to Learn:

  • How 3D-Bioprinted Tumors Respond to Therapy: Understand how these models react to standard-of-care drugs, offering valuable insights into their therapeutic potential
  • The Similarity of Carcinotech’s Tumors to Native Tumors: Visualise how our engineered tumors closely mimic the donor’s tumour microenvironment
  • Applications Beyond Lung Cancer: Discover how 3D cancer models can be applied to various cancer types and therapeutic modalities
  • The Biofabrication Process: Explore the cutting-edge biofabrication methods that enable us to produce tumors 99% similar to the original biopsy

Get Your Copy Today!

Download your copy of the Carcinotech Application Note and learn how 3D-bioprinted tumours can serve as a valuable tool for developing your lung cancer therapeutic.

Application Note Gated Form